Geneos Wealth Management’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Geneos Wealth Management’s Portfolio IBDT Stock Details IBDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,700	Closed	-$67K	–	2280
2022 Q2	$67K	Hold	2,700	–	–	﹤0.01%	1160
2022 Q1	$71K	Hold	2,700	–	–	﹤0.01%	1221
2021 Q4	$76K	Hold	2,700	–	–	﹤0.01%	1286
2021 Q3	$77K	Hold	2,700	–	–	﹤0.01%	1271
2021 Q2	$77K	Hold	2,700	–	–	﹤0.01%	1274
2021 Q1	$77K	Hold	2,700	–	–	﹤0.01%	1407
2020 Q4	$76K	Hold	2,700	–	–	﹤0.01%	1255
2020 Q3	$78K	Buy	+2,700	New	+$79K	﹤0.01%	1053

Other funds holding IBDT

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.22B AUM 22.28% 1-Year Est. Return

Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $1.89B AUM 14.55% 1-Year Est. Return

Klingman & Associates New York $2.09B AUM 16.49% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Geneos Wealth Management's IBDT Position: Q3 2022 in Review

Geneos Wealth Management sold out of iShares iBonds Dec 2028 Term Corporate ETF (IBDT) in Q3 2022, closing a stake of 2,700 shares — an estimated $67K sold.

Geneos Wealth Management first reported a position in IBDT in Q3 2020 and held it in 8 quarters. The position peaked at $78K in Q3 2020. 103 funds tracked by Wall St. Rank hold IBDT as of Q3 2022.

Geneos Wealth Management reported no remaining iShares iBonds Dec 2028 Term Corporate ETF position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 2,700 iShares iBonds Dec 2028 Term Corporate ETF shares in Q3 2022, an estimated $67K.
Geneos Wealth Management first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q3 2020 and held it in 8 quarters.
Geneos Wealth Management's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $78K in Q3 2020.
103 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.